No Picture
News

THE VETS LAUNCH 4 CITIES IN 45 DAYS

Mobile veterinarian care expands its services into Charlotte, Sacramento, Phoenix, and San Diego CHARLOTTE, N.C., May 10, 2022 /PRNewswire/ — The Vets, a mobile veterinary service providing premium at-home pet care, announces its expansion into […]

No Picture
News

Evofem Biosciences to Decrease Cost of Goods 45 Percent Through New Partnership with Bora Pharmaceutical Services for the Commercial Manufacturing of Phexxi®

SAN DIEGO, May 10, 2022 /PRNewswire/ — Evofem Biosciences, Inc., (Nasdaq: EVFM) today announced it has selected Bora Pharmaceuticals Services Inc. (Bora) Canada as Evofem’s new contract manufacturing organization (CMO). Bora will eventually manufacture Phexxi® […]

No Picture
News

Millennium Health and the University of Cincinnati Conducting NIDA-Funded Research Regarding Precipitated Withdrawal During Buprenorphine Induction

SAN DIEGO–(BUSINESS WIRE)–Millennium Health, an accredited specialty laboratory specializing in medication monitoring and drug testing, is collaborating with investigators from the University of Cincinnati (UC) to investigate precipitated withdrawal during buprenorphine induction. “Despite the demonstrated […]

No Picture
News

Recordati Rare Diseases Announces Multiple Scientific Abstracts to Be Highlighted at American Association of Clinical Endocrinology

LEBANON, N.J.–(BUSINESS WIRE)–Recordati Rare Diseases Inc. announced today that various scientific abstracts have been accepted and will be featured onsite at the American Association of Clinical Endocrinology (AACE) annual meeting being held in San Diego, […]

No Picture
News

Hitachi High-Tech and Invivoscribe partner to advance molecular diagnostics and precision medicine

SAN DIEGO, May 9, 2022 /PRNewswire/ — Hitachi High-Tech Corporation (“Hitachi High-Tech”) has entered into a strategic partnership (the Partnership) with Invivoscribe, Inc. (“Invivoscribe”), a global provider of blood cancer testing kits and services, by […]

No Picture
News

Aspen Neuroscience Announces $147.5 Million Series B Financing, Led by GV, LYFE Capital and Revelation Partners

Will Fund Clinical Trials of Company’s First iPSC-derived Autologous Dopamine Neuron Replacement for Parkinson’s Disease SAN DIEGO, May 9, 2022 /PRNewswire/ — Aspen Neuroscience, Inc., a private biotechnology company developing autologous cell therapies, including the […]

No Picture
News

Exclusive: Aspen Neuroscience collects large Series B to compete against Bayer’s Parkinson’s cell therapy

Damien McDevitt thinks frequently about the name Aspen Neuroscience. Specifically, should the neuroscience portion be dropped as the San Diego biotech considers expanding beyond the CNS? McDevitt, the 21-year GlaxoSmithKline veteran and former Akcea Therapeutics […]

No Picture
News

Ironwood Pharmaceuticals to Present New IW-3300 and Linaclotide Data at Digestive Disease Week® 2022

BOSTON–(BUSINESS WIRE)–Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that the company and its collaborators will present eight studies, including two oral presentations, during the Digestive Disease Week® (DDW) 2022 meeting being […]

No Picture
News

Equillium Announces Three Poster Presentations at the Annual Meeting of The American Association of Immunologists

LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced that three posters were […]

No Picture
News

Ethos Asset Management Inc., USA Announces Deal with Ecom Mortgage, Inc., to Grow its Core Mortgage Brokering and Banking Business by Increasing its Assets Under Management

Partnership Provides Long Term Financing to Ecom Mortgage, already established in the industry as a full-service direct mortgage lender with an outstanding team offering expertise in every area of mortgage lending, from purchasing to refinancing […]

No Picture
News

Evofem Presents Data Detailing Fewer Urinary Tract Infections in Women Using Phexxi in the Phase 3 AMPOWER Clinical Trial

5.8% of Women in the AMPOWER Trial Experienced an On-Study Urinary Tract Infection Compared to 11% in the General Population The Post hoc Analysis will be Presented at the 2022 American College of Obstetricians and […]

News

With Aduhelm in tatters, the search is on for Michel Vounatsos’ replacement at Biogen; David Liu, Roger Perlmutter join insitro’s SAB

Michel Vounatsos ? Because of the dearth of Alzheimer’s treatments, Biogen pushed aggressively to cross the regulatory goal line with aducanumab despite early trial wrap-ups and pervasive efficacy questions. The highly controversial approval of Aduhelm, […]

No Picture
News

DATA FROM NOVEL, EXPLORATORY ANALYSIS OF INTERMITTENT VALTOCO® (DIAZEPAM NASAL SPRAY) CIV USE INDICATES MORE THAN TWO-FOLD INCREASE IN MEAN INTERVAL BETWEEN SEIZURE CLUSTERS

Neurelis presents two posters at the 2nd North American Epilepsy Congress (NAEC) highlighting new analysis of change in timing between seizure clusters across 12 months, and final effectiveness and safety data from the Phase 3, […]

No Picture
News

Regulus Therapeutics Announces Timing for First Quarter 2022 Financial Results Webcast and Conference Call

SAN DIEGO, May 5, 2022 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the “Company” or “Regulus”), today announced that it will […]